Form 8-K - Current report:
SEC Accession No. 0001104659-25-047402
Filing Date
2025-05-13
Accepted
2025-05-12 17:58:55
Documents
14
Period of Report
2025-05-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2513856d1_8k.htm   iXBRL 8-K 52910
  Complete submission text file 0001104659-25-047402.txt   302817

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA abbv-20250508.xsd EX-101.SCH 4500
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abbv-20250508_def.xml EX-101.DEF 29640
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE abbv-20250508_lab.xml EX-101.LAB 40036
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abbv-20250508_pre.xml EX-101.PRE 27848
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2513856d1_8k_htm.xml XML 10622
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 25936422
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)